BIOMAT Database Logo BIOMAT Database Logo

Immunological features of Wegener's granulomatosis. 1974

E J Shillitoe, and T Lehner, and M H Lessof, and D F Harrison

UI MeSH Term Description Entries
D006968 Hypersensitivity, Delayed An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS. Hypersensitivity, Tuberculin-Type,Hypersensitivity, Type IV,Tuberculin-Type Hypersensitivity,Type IV Hypersensitivity,Delayed Hypersensitivity,Delayed Hypersensitivities,Hypersensitivity, Tuberculin Type,Tuberculin Type Hypersensitivity,Tuberculin-Type Hypersensitivities,Type IV Hypersensitivities
D007105 Immune Complex Diseases Group of diseases mediated by the deposition of large soluble complexes of antigen and antibody with resultant damage to tissue. Besides SERUM SICKNESS and the ARTHUS REACTION, evidence supports a pathogenic role for immune complexes in many other IMMUNE SYSTEM DISEASES including GLOMERULONEPHRITIS, systemic lupus erythematosus (LUPUS ERYTHEMATOSUS, SYSTEMIC) and POLYARTERITIS NODOSA. Hypersensitivity, Type III,Type III Hypersensitivity,Disease, Immune Complex,Diseases, Immune Complex,Hypersensitivities, Type III,Immune Complex Disease,Type III Hypersensitivities
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D002464 Cell Migration Inhibition Phenomenon of cell-mediated immunity measured by in vitro inhibition of the migration or phagocytosis of antigen-stimulated LEUKOCYTES or MACROPHAGES. Specific CELL MIGRATION ASSAYS have been developed to estimate levels of migration inhibitory factors, immune reactivity against tumor-associated antigens, and immunosuppressive effects of infectious microorganisms. Chemotaxis Inhibition,Chemotaxis Inhibitions,Inhibition, Chemotaxis,Inhibitions, Chemotaxis
D005260 Female Females

Related Publications

E J Shillitoe, and T Lehner, and M H Lessof, and D F Harrison
Letter: Immunological features of Wegener's granulomatosis.
April 1974, Lancet (London, England),
E J Shillitoe, and T Lehner, and M H Lessof, and D F Harrison
Wegener's granulomatosis. Unusual features.
September 1969, New York state journal of medicine,
E J Shillitoe, and T Lehner, and M H Lessof, and D F Harrison
Oral features of Wegener's granulomatosis.
April 1985, Archives of otolaryngology (Chicago, Ill. : 1960),
E J Shillitoe, and T Lehner, and M H Lessof, and D F Harrison
Presenting features in Wegener's granulomatosis.
September 1988, BMJ (Clinical research ed.),
E J Shillitoe, and T Lehner, and M H Lessof, and D F Harrison
Unusual radiographic features of Wegener's granulomatosis.
February 1978, AJR. American journal of roentgenology,
E J Shillitoe, and T Lehner, and M H Lessof, and D F Harrison
The cytologic features of Wegener's granulomatosis.
July 1998, American journal of clinical pathology,
E J Shillitoe, and T Lehner, and M H Lessof, and D F Harrison
Clinical features of childhood granulomatosis with polyangiitis (wegener's granulomatosis).
January 2014, Pediatric rheumatology online journal,
E J Shillitoe, and T Lehner, and M H Lessof, and D F Harrison
[Wegener's granulomatosis. Clinical, immunological and autopsy findings].
February 1971, Schweizerische medizinische Wochenschrift,
E J Shillitoe, and T Lehner, and M H Lessof, and D F Harrison
Clinical features and outcome of pediatric Wegener's granulomatosis.
June 2007, Arthritis and rheumatism,
E J Shillitoe, and T Lehner, and M H Lessof, and D F Harrison
Wegener's granulomatosis exhibiting the clinical features of Goodpasture's syndrome.
January 1981, International urology and nephrology,
Copied contents to your clipboard!